Prestigious Research Fellowship awarded to Dr Mo Chen

Img 5359

We are thrilled to announce that because of your generous support, the Foundation is co-funding Dr Mo Chen’s prestigious research fellowship.

Griffith University awarded just 12 Postdoctoral Research Fellowships across the university. These fellowships are designed to support the best and brightest researchers so that they can continue outstanding research and then apply for nationally-competitive fellowships.

Dr Mo Chen obtained his PhD in 2019 at Griffith University and then has continued in the Spinal Injury Team as a research fellow. He has invented the cellular nerve bridge which is crucial for the spinal cord therapy that is now progressing to clinical trial. 

Mo was awarded the prestigious Research Australia Discovery Award 2021-2022 for this invention.

Mo has now identified additional improvements to the nerve bridge that will further enhance the function and regenerative capacity. With this fellowship, Mo will be able to conduct pre-clinical research with the aim of introducing the improvements to augment future versions of the human therapy.

Congratulations Dr Mo Chen!

Special thank you to our supporters to have helped fund this Dr Mo Chen’s Fellowship with a total investment from the Foundation of $149,000 over two years.



Share this great article

Newsletter Signup

Heading

Sub heading here

[FORM_HERE]
TOP POPUP CONTENT HERE...
LEFT POPUP CONTENT HERE...
BOTTOM POPUP CONTENT HERE...

Share This

Select your desired option below to share a direct link to this page

Perry Cross Logo

Spinal Injury Project Research

Perry Cross Logo

LIVINWell Free Online Webinar

Register to receive your free gift
Perry Cross Logo Blk@2x

Leave a Gift in Your Will

A legacy gift to the Perry Cross Spinal Research Foundation will help us continue the journey to discover a cure for paralysis and its many complexities.

You can help people across the world to walk again. We can’t thank you enough for considering us.

Please contact us on
0457 277 579 for a confidential discussion.